Effects of Menstrual Cycle Phases on Gait, Pelvis, and Sleep

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-01

Study Completion Date

2026-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the effects of different phases of the menstrual cycle on gait spatiotemporal characteristics, pelvic kinematics, and sleep quality in healthy women aged 18-35 years with regular menstrual cycles. Participants will be assessed in three phases of the cycle: early follicular (days 1-3), ovulation (days 7-9, confirmed by ovulation test), and luteal (days 20-23). Gait parameters and pelvic kinematics will be evaluated using the BTS-G walk sensor system, while sleep quality will be assessed with the Pittsburgh Sleep Quality Index (PSQI). The study seeks to determine whether physiological and hormonal changes during menstrual phases lead to measurable differences in gait, pelvic motion, and sleep quality.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Yoga on Balance, Cognition, Posture, and Body Awareness in Premenstrual Syndrome (PMS)

NCT06785766

Premenstrual Syndrome-PMS

ENROLLING_BY_INVITATION NA

Effect of a Calisthenic Exercises on Premenstrual Symptoms

NCT06530368

Menstrual Pain

COMPLETED NA

Premenstrual Syndrome and Physical Activity Self-Worth

NCT05692479

Premenstrual Syndrome

COMPLETED

Clinical Pilates' Impact on Fitness, Symptoms & Kinesiophobia in PMS

NCT06835062

Premenstrual Syndrome Pilates Exercise

COMPLETED NA

Physical Performance of Women at Different Stages of the Menstrual Cycle, and Photobiomodulation Therapy

NCT04281446

Menstrual Cycle Disorder

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This cross-sectional, prospective observational study investigates the influence of menstrual cycle phases on gait spatiotemporal characteristics, pelvic kinematics, and sleep quality in healthy women aged 18-35 years with regular menstrual cycles (28 ± 7 days). Hormonal changes during the cycle may affect musculoskeletal performance, balance, and sleep quality, yet the extent of these effects on gait and pelvic motion has not been fully clarified.

Participants will be evaluated in three phases of their menstrual cycle:

Early follicular phase (days 1-3), determined by the onset of menstrual bleeding, Ovulation phase (days 7-9), confirmed by a salivary ovulation test, Luteal phase (days 20-23), approximately 6-8 days after ovulation. At each phase, gait spatiotemporal parameters (speed, cadence, stride length, stance and swing phases, gait cycle duration) and pelvic kinematics (tilt, obliquity, rotation symmetry) will be assessed using the BTS-G walk wireless sensor system. Sleep quality will be measured with the Pittsburgh Sleep Quality Index (PSQI).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menstrual Cycle Sleep Gait

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Women with Regular Menstrual Cycles

Women aged 18-35 years with regular menstrual cycles (28 ± 7 days), evaluated prospectively during early follicular, ovulation, and luteal phases.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female, aged 18-35 years
* Voluntarily agrees to participate and provides informed consent
* Regular menstrual cycle (28 ± 7 days)
* Able to comply with study assessments and procedures

Exclusion Criteria

* History of surgery within the past 6 months
* Current or chronic low back pain
* Dysmenorrhea complaints
* Neurological or orthopedic disorders affecting gait or muscle strength
* Presence of spinal deformities
* Rheumatologic disease
* Climacteric or menopausal period
* Any condition that may affect gait, pelvic kinematics, or sleep quality

Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes